Clinical Trial Update: Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This trial result updates a Phase 1/2 study evaluating carfilzomib with rituximab and a chemotherapy regimen in adults with diffuse large B-cell lymphoma. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Combination chemotherapy regimen
• Kyprolis (carfilzomib) (carfilzomib)
• Rituxan (rituximab) (rituximab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-29